Literature DB >> 8269281

Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia.

S J Urbanski1, D R Edwards, N Hershfield, S A Huchcroft, E Shaffer, L Sutherland, A E Kossakowska.   

Abstract

Several studies have implicated the extracellular matrix-degrading metalloproteinases (MMPs) as essential agents in tumor cell invasion and metastasis. In the present study, we have investigated the patterns of expression of a number of MMPs and their specific tissue inhibitors (TIMP-1 and TIMP-2) in human colonic tissue samples that represent various stages of progression from adenomas showing different degrees of dysplasia to adenocarcinomas. We assessed levels of mRNA by Northern blot analysis and the results were measured semiquantitatively by densitometry. In total, we analyzed nine adenomas of varying size and with varying degrees of dysplasia, three adenomas with adenocarcinoma (malignant polyps), and five adenocarcinomas. Although expression of MMP and TIMP mRNA was highly intercorrelated, transcripts for stromelysin 3 and TIMP-2 (high) showed the strongest relation to the neoplastic process. Detection of stromelysin 3 mRNA accompanied a diagnosis of severe dysplasia or malignancy, whereas levels of TIMP-2 (high) mRNA transcripts permitted finer distinctions on the neoplastic continuum. These data indicate changes within extracellular matrix acquired during the process of malignant transformation of human sporadic colorectal neoplasia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8269281

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  17 in total

Review 1.  The matrix metalloproteinases and their inhibitors in pancreatic cancer. From molecular science to a clinical application.

Authors:  S R Bramhall
Journal:  Int J Pancreatol       Date:  1997-02

2.  Claudin-4 expression is associated with tumor invasion, MMP-2 and MMP-9 expression in gastric cancer.

Authors:  Tsann-Long Hwang; Li-Yu Lee; Chee-Chan Wang; Ying Liang; Shu-Fang Huang; Chi-Ming Wu
Journal:  Exp Ther Med       Date:  2010-07-12       Impact factor: 2.447

3.  Stromelysin-3 expression in early (pT1) carcinomas and pseudoinvasive lesions of the colorectum.

Authors:  J Mueller; E Mueller; E Arras; B Bethke; M Stolte; H Höfler
Journal:  Virchows Arch       Date:  1997-03       Impact factor: 4.064

4.  Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer.

Authors:  Ki-Nam Shim; Sung-Ae Jung; Yang-Hee Joo; Kwon Yoo
Journal:  J Gastroenterol       Date:  2007-03-12       Impact factor: 7.527

5.  Effect of the expression of matrix metalloproteases and their tissue inhibitors on survival of patients with resectable colorectal cancer.

Authors:  Lucía González; Noemí Eiró; Luis O González; Alejandro Andicoechea; Esther Barbón; José L García-Muñiz; Francisco J Vizoso
Journal:  Dig Dis Sci       Date:  2012-04-10       Impact factor: 3.199

6.  Matrix metalloproteinases and their inhibitors in gastric cancer.

Authors:  G I Murray; M E Duncan; E Arbuckle; W T Melvin; J E Fothergill
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

7.  Balance between activation and inhibition of matrix metalloproteinase-2 (MMP-2) is altered in colorectal tumors compared to normal colonic epithelium.

Authors:  Deborah L Ornstein; Kenneth H Cohn
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

8.  Usefulness of MMP-9/TIMP-1 in predicting tumor recurrence in patients undergoing curative surgical resection for gastric carcinoma.

Authors:  Yeon Seok Seo; Jong-Jae Park; Ji Hoon Kim; Jin Yong Kim; Jong Eun Yeon; Jae Seon Kim; Kwan Soo Byun; Young-Tae Bak
Journal:  Dig Dis Sci       Date:  2007-03       Impact factor: 3.487

Review 9.  Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas.

Authors:  Xiao-Feng Sun; Hong Zhang
Journal:  Mol Cancer       Date:  2006-10-06       Impact factor: 27.401

10.  Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinoma.

Authors:  Zhen-kui Qiao; Yan-long Li; Hong-tao Lu; Ke-liang Wang; Wan-hai Xu
Journal:  World J Surg Oncol       Date:  2013-01-03       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.